NCT02615405View on ClinicalTrials.gov

Phospholipid Hypothesis of Depression: From Molecular Biology, Neuroimaging to Behaviour

NACompletedINTERVENTIONAL
Enrollment

240

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Major Depressive Disorder
Interventions
DIETARY_SUPPLEMENT

EPA

A daily treatment of 5 identical capsules of EPA (3.5 g/d) for Studies 1 \& 2.

DIETARY_SUPPLEMENT

DHA

A daily treatment of 5 identical capsules of DHA (1.75 g/d) for Studies 1 \& 2.

DIETARY_SUPPLEMENT

Placebo

A daily treatment of 5 identical capsules of placebo (high oleic oil) in single or divided administration for Study 1.

Trial Locations (1)

403

China Medical University Hospital, Taichung

All Listed Sponsors
lead

National Science and Technology Council, Taiwan

OTHER_GOV

NCT02615405 - Phospholipid Hypothesis of Depression: From Molecular Biology, Neuroimaging to Behaviour | Biotech Hunter | Biotech Hunter